Chemical and Biological Mechanisms of Pathogen Reduction Technologies

Overview

Journal Photochem Photobiol

Specialties Biochemistry
Biology
Chemistry

Date 2014 Jul 22

PMID 25041351

Citations 30

Authors

Janna M Mundt

Lindsay Rouse

Jeroen Van den Bossche

Raymond P Goodrich

Affiliations

Soon will be listed here.

Abstract

Within the last decade new technologies have been developed and implemented which employ light, often in the presence of a photosensitizer, to inactivate pathogens that reside in human blood products for the purpose of transfusion. These pathogen reduction technologies attempt to find the proper balance between pathogen kill and cell quality. Each system utilizes various chemistries that not only impact which pathogens they can inactivate and how, but also how the treatments affect the plasma and cellular proteins and to what degree. This paper aims to present the various chemical mechanisms for pathogen reduction in transfusion medicine that are currently practiced or in development.

Citing Articles

Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks.

da Gama A, Soeiro M Pathogens. 2025; 14(2).

PMID: 40005511 PMC: 11858163. DOI: 10.3390/pathogens14020133.

Ultraviolet light and riboflavin accelerates red blood cell dysfunction in vitro and in a guinea pig transfusion model.

Baek J, Shin H, Xu F, Zhang X, Williams M, Gao Y Blood Transfus. 2024; 22(4):316-327.

PMID: 38814883 PMC: 11251826. DOI: 10.2450/BloodTransfus.718.

Latest Advances in 3D Bioprinting of Cardiac Tissues.

Jafari A, Ajji Z, Mousavi A, Naghieh S, Bencherif S, Savoji H Adv Mater Technol. 2023; 7(11).

PMID: 38044954 PMC: 10691862. DOI: 10.1002/admt.202101636.

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies.

Cardoso M, Ragan I, Hartson L, Goodrich R Pathogens. 2023; 12(7).

PMID: 37513758 PMC: 10383627. DOI: 10.3390/pathogens12070911.

antimicrobial efficacy of riboflavin, ultraviolet-A radiation, and combined riboflavin/ultraviolet-A radiation on ocular pathogens.

Sharma A, Sharma R, Chander J, Nirankari V Taiwan J Ophthalmol. 2023; 13(1):21-27.

PMID: 37252159 PMC: 10220446. DOI: 10.4103/tjo.tjo_28_21.

References

Marschner S, Goodrich R . Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfus Med Hemother. 2011; 38(1):8-18. PMC: 3132976. DOI: 10.1159/000324160. View

Muller-Breitkreutz K, Mohr H . Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma. J Med Virol. 1998; 56(3):239-45. DOI: 10.1002/(sici)1096-9071(199811)56:3<239::aid-jmv11>3.0.co;2-9. View

Gonzalez E . PUVA for psoriasis. Dermatol Clin. 1995; 13(4):851-66. View

Hayes E, Gubler D . West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med. 2006; 57:181-94. DOI: 10.1146/annurev.med.57.121304.131418. View

Elikaei A, Hosseini S, Sharifi Z, Latifi H, Nikbakht H, Mirshafiee H . Methylene blue based device for pathogen reduction in human plasma. Iran J Ped Hematol Oncol. 2014; 3(3):97-102. PMC: 3921873. View

Asano H, Lee C, Fox-Talbot K, Koh C, Erdinc M, Marschner S . Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation. 2007; 84(9):1174-82. DOI: 10.1097/01.tp.0000287318.94088.d7. View

Haugaa H, Taraldsrud E, Nyrerod H, Tonnessen T, Foss A, Solheim B . Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma. Clin Med Res. 2014; 12(1-2):27-32. PMC: 4453305. DOI: 10.3121/cmr.2013.1168. View

Cardo L, Salata J, Mendez J, Reddy H, Goodrich R . Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci. 2007; 37(2):131-7. DOI: 10.1016/j.transci.2007.07.002. View

El Chaar M, Atwal S, Freimanis G, Dinko B, Sutherland C, Allain J . Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion. 2013; 53(12):3174-83. DOI: 10.1111/trf.12235. View

10.

Lescoutra-Etchegaray N, Sumian C, Culeux A, Durand V, Gurgel P, Deslys J . Removal of exogenous prion infectivity in leukoreduced red blood cells unit by a specific filter designed for human transfusion. Transfusion. 2013; 54(4):1037-45. DOI: 10.1111/trf.12420. View

11.

Henriques B, Olsen R, Bross P, Gomes C . Emerging roles for riboflavin in functional rescue of mitochondrial β-oxidation flavoenzymes. Curr Med Chem. 2010; 17(32):3842-54. DOI: 10.2174/092986710793205462. View

12.

Yurdakok M, Erdem G, Tekinalp G . Riboflavin in the treatment of neonatal hyperbilirubinemia. Turk J Pediatr. 1988; 30(3):159-61. View

13.

Zolfaghari P, Packer S, Singer M, Nair S, Bennett J, Street C . In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol. 2009; 9:27. PMC: 2642833. DOI: 10.1186/1471-2180-9-27. View

14.

Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A . A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion. 2009; 49(12):2612-24. DOI: 10.1111/j.1537-2995.2009.02334.x. View

15.

Wagner S, Skripchenko A, Robinette D, Mallory D, Hirayama J, Cincotta L . The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions. Dev Biol (Basel). 2000; 102:125-9. View

16.

Salah M, Samy N, Fadel M . Methylene blue mediated photodynamic therapy for resistant plaque psoriasis. J Drugs Dermatol. 2009; 8(1):42-9. View

17.

Fast L, DiLeone G, Marschner S . Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion. 2010; 51(7):1397-404. DOI: 10.1111/j.1537-2995.2010.02984.x. View

18.

Hardwick C, Herivel T, Hernandez S, Ruane P, Goodrich R . Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology. Photochem Photobiol. 2004; 80(3):609-15. DOI: 10.1562/2004-04-14-TSN-139. View

19.

Honigsmann H . Phototherapy for psoriasis. Clin Exp Dermatol. 2001; 26(4):343-50. DOI: 10.1046/j.1365-2230.2001.00828.x. View

20.

Schagen F, Moor A, Cheong S, Cramer S, Van Ormondt H, Van Der Eb A . Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation. Gene Ther. 1999; 6(5):873-81. DOI: 10.1038/sj.gt.3300897. View